Potential damage in pulmonary arterial hypertension: An experimental study of pressure-induced damage of pulmonary artery.
Yuheng WangHamidreza GharahiMarissa R GrobbelAkshay RaoSara RoccabiancaSeungik BaekPublished in: Journal of biomedical materials research. Part A (2020)
Pulmonary arterial hypertension (PAH) is associated with elevated pulmonary arterial pressure. PAH prognosis remains poor with a 15% mortality rate within 1 year, even with modern clinical management. Previous clinical studies proposed wall shear stress (WSS) to be an important hemodynamic factor affecting cell mechanotransduction, growth and remodeling, and disease progress in PAH. However, WSS in vivo is typically at most 2.5 Pa and a doubt has been cast whether WSS alone can drive disease progress. Furthermore, our current understanding of PAH pathology largely comes from small animals' studies in which caliber enlargement, a hallmark of PAH in humans, is rarely reported. Therefore, a large-animal experiment on pulmonary arteries (PAs) is needed to validate whether increased pressure can induce enlargement of PAs caliber. In this study, we use an inflation testing device to characterize the mechanical behavior, both nonlinear elastic behavior and irreversible damage of porcine arteries. The parameters of elastic behavior are estimated from the inflation test at a low-pressure range before and after over-pressurization. Then, histological images are qualitatively examined for medial and adventitial layers. This study sheds light on the relevance of pressure-induced damage mechanism in human PAH.
Keyphrases
- pulmonary arterial hypertension
- pulmonary artery
- pulmonary hypertension
- polycyclic aromatic hydrocarbons
- oxidative stress
- coronary artery
- diabetic rats
- high glucose
- endothelial cells
- type diabetes
- deep learning
- cardiovascular disease
- stem cells
- drug induced
- coronary artery disease
- blood flow
- cell therapy
- risk assessment